Orai1 Contributes to Platelet-Activating Factor (PAF)-Induced Contraction in Association with Voltage-Dependent Ca2+
Keisuke Obara1, Daiki Kato1, Marina Yuguchi1
1Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.
Abstract:
Platelet-activating factor (PAF) is known to induce smooth muscle contraction; however, its mechanisms in urinary bladder smooth muscle (UBSM) remain unclear. We investigated the involvement of Orai1 in PAF-induced contraction in guinea pig UBSM. PAF (10-6 M)-induced contraction was markedly inhibited by the Orai1 inhibitor Synta66 (10-5 M) and the L-type voltage-dependent Ca2+ channel (VDCC) inhibitor verapamil (10-5 M). Similarly, under Ca2+-free conditions with store depletion induced by cyclopiazonic acid (3 × 10-5 M), Ca2+-induced contraction was suppressed by Synta66 and verapamil. In contrast, Synta66 only partially inhibited contractions induced by acetylcholine (10-5 M) and α,β-methylene ATP (3 × 10-6 M), and it had no effect on high-potassium chloride (80 mM)-induced contraction. Inhibition of Na+/Ca2+ exchanger 1 (NCX1), transient receptor potential canonical (TRPC) 1/4/5 channels, or anoctamin 1 (ANO1) did not significantly affect PAF-induced contraction. These findings suggest that Orai1 contributes to PAF-induced contraction in association with VDCC-dependent mechanisms, whereas NCX1, TRPC1/4/5 channels, and ANO1 play limited roles under these conditions.
Related Concept Videos
Nitric Oxide Signaling Pathway
G-Protein Gated Ion Channels
Sensory organs,...
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...


